Search research articles
Contact Us
Filters
Showing results (131-140 of 234) with videos related to
Page
of 24
Sort By:
Seminars in Arthritis and Rheumatism
|
August 1, 1997
Therapy with cyclosporine in psoriatic arthritis
I Olivieri, C Salvarani, F Cantini, et al.
Clinical and Experimental Rheumatology
|
September 25, 2007
Circulating RANKL/OPG in polymyalgia rheumatica
L Pulsatelli, P Dolzani, T Silvestri, et al.
Clinical and Experimental Rheumatology
|
May 18, 2005
Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography
A Vaglio, P Greco, A Versari, et al.
Arthritis and Rheumatism
|
November 1, 1994
Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica
C Salvarani, S E Gabriel, M A Gertz, et al.
Clinical and Experimental Rheumatology
|
July 20, 1999
Treatment of thrombophlebitis of Behçet's disease with low dose cyclosporin A
F Cantini, C Salvarani, L Niccoli, et al.
The Journal of Rheumatology
|
February 1, 1990
Upper limb lymphedema in psoriatic arthritis
C Salvarani, P L Macchioni, M Veneziani, et al.
Clinical and Experimental Rheumatology
|
March 17, 2006
Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis
C Salvarani, I Olivieri, N Pipitone, et al.
Rheumatology International
|
July 22, 1998
The relationship between serum-soluble interleukin-2 receptor and radiological evolution in psoriatic arthritis patients treated with cyclosporin-A
P Macchioni, L Boiardi, T Cremonesi, et al.
The Journal of Rheumatology
|
October 1, 1994
Serum soluble CD4 and CD8 levels in polymyalgia rheumatica
C Salvarani, L Boiardi, P Macchioni, et al.
Clinical and Experimental Rheumatology
|
July 1, 1994
Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment
L Boiardi, P Macchioni, C Salvarani, et al.
Page
of 24
Search research articles
Search
Showing results (131-140 of 234) with videos related to
Sort By:
Page
of 24
Seminars in Arthritis and Rheumatism
|
August 1, 1997
Therapy with cyclosporine in psoriatic arthritis
I Olivieri, C Salvarani, F Cantini, et al.
Clinical and Experimental Rheumatology
|
September 25, 2007
Circulating RANKL/OPG in polymyalgia rheumatica
L Pulsatelli, P Dolzani, T Silvestri, et al.
Clinical and Experimental Rheumatology
|
May 18, 2005
Post-treatment residual tissue in idiopathic retroperitoneal fibrosis: active residual disease or silent "scar" ? A study using 18F-fluorodeoxyglucose positron emission tomography
A Vaglio, P Greco, A Versari, et al.
Arthritis and Rheumatism
|
November 1, 1994
Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica
C Salvarani, S E Gabriel, M A Gertz, et al.
Clinical and Experimental Rheumatology
|
July 20, 1999
Treatment of thrombophlebitis of Behçet's disease with low dose cyclosporin A
F Cantini, C Salvarani, L Niccoli, et al.
The Journal of Rheumatology
|
February 1, 1990
Upper limb lymphedema in psoriatic arthritis
C Salvarani, P L Macchioni, M Veneziani, et al.
Clinical and Experimental Rheumatology
|
March 17, 2006
Recommendations of the Italian Society for Rheumatology for the use of biologic (TNF-alpha blocking) agents in the treatment of psoriatic arthritis
C Salvarani, I Olivieri, N Pipitone, et al.
Rheumatology International
|
July 22, 1998
The relationship between serum-soluble interleukin-2 receptor and radiological evolution in psoriatic arthritis patients treated with cyclosporin-A
P Macchioni, L Boiardi, T Cremonesi, et al.
The Journal of Rheumatology
|
October 1, 1994
Serum soluble CD4 and CD8 levels in polymyalgia rheumatica
C Salvarani, L Boiardi, P Macchioni, et al.
Clinical and Experimental Rheumatology
|
July 1, 1994
Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment
L Boiardi, P Macchioni, C Salvarani, et al.
Page
of 24